Saroja Pharma IPO GMP Today ( Grey Market Premium )

Saroja Pharma IPO GMP Today ( Grey Market Premium )

The Saroja Pharma IPO commenced on August 31, 2023, and concluded on September 5, 2023. The allotment of shares took place on September 8, 2023, and the initiation of refunds began on September 11, 2023. The shares were credited to the demat accounts of investors on September 12, 2023. Finally, the listing of Saroja Pharma on the stock exchange occurred on September 13, 2023.

The Saroja Pharma IPO was priced at ₹84 per share, with a lot size of 1600. The total issue size was ₹9.11 crores, comprising a fresh issue of 9.11 crores. The IPO was listed on the NSE SME.

In terms of quota reservations, the other quota was reserved for 50% of the shares and the retail quota was reserved for 50% of the shares.

Saroja Pharma Industries India Limited IPO Basic Details

Company NameSaroja Pharma Industries India Limited
Domain of CompanyTrade, export, and supply of Specialty Chemicals
and Active Pharmaceutical Ingredients (APIs)
Saroja Pharma Industries IPO GMP Today₹0.00
Saroja Pharma Industries IPO Listing Gain0.00%
Saroja Pharma Industries IPO Open DateAugust 31, 2023
Saroja Pharma Industries IPO Close DateSeptember 5, 2023
Saroja Pharma Industries IPO Allotment DateSeptember 8, 2023
Saroja Pharma Industries IPO Listing DateSeptember 13, 2023
Face Value₹10 per share
Price₹84 per share
Lot Size1600 Shares
Issue Size1,084,800 shares of ₹10
(aggregating up to ₹9.11 Cr)
Fresh Issue1,084,800 shares of ₹10
(aggregating up to ₹9.11 Cr)
Issue TypeFixed Price Issue IPO
Listing AtNSE SME
Company PromotersMr. Biju Gopinathan Nair And
Mr. Manish Dasharath Kamble

Saroja Pharma IPO GMP Today:

DateGMPListing GainKostakSubject to
6 September 2023₹00.00%
5 September 2023₹00.00%
4 September 2023₹00.00%
3 September 2023₹00.00%
2 September 2023₹00.00%
1 September 2023₹00.00%
31 August 2023₹00.00%

Saroja Pharma IPO Details:

Established in 2019, Saroja Pharma Industries India Limited specializes in the trading, exporting, and distribution of Specialty Chemicals and Active Pharmaceutical Ingredients (APIs). The company operates within three primary product categories: Chemicals, Pharma Intermediaries, and Veterinary Pharma API. Their product portfolio includes items like Liquid Bromine, employed as an agricultural intermediate, as well as Ethyl Acetate, utilized as an API solvent. Additionally, they supply various pharmaceutical products, both for human and veterinary use, some of which serve as API solvents.

APIs, also known as bulk drugs or bulk actives, are the core constituents in the production of finished dosages, such as capsules, tablets, liquids, and other dosage forms, sometimes combined with other APIs or inert ingredients.

Saroja Pharma Industries India Limited primarily exports its products to destinations like Pakistan, Egypt, Russia, Jordan, Hong Kong, and Singapore.

Key Competitive Advantages:

  1. A seasoned team of promoters and management professionals.
  2. A scalable business model designed for growth.
  3. A comprehensive and diversified range of products.
  4. Varied business operations contributing to a diverse revenue base.

Saroja Pharma IPO More Details Click Here

Saroja Pharma IPO FAQs

When is Saroja Pharma IPO open?

Saroja Pharma IPO will open on 31 August 2023.

When is Saroja Pharma IPO Close?

Saroja Pharma IPO will be closed on 5 September 2023.

What is Saroja Pharma IPO GMP Today?

The Saroja Pharma IPO GMP aka Grey Market Premium is ₹0.

What is Saroja Pharma IPO Kostak Rates Today?

The Saroja Pharma IPO Kostak Rate is ₹000.

What is Saroja Pharma IPO Subject to Sauda Price Today?

The Saroja Pharma IPO subject to sauda rates is ₹000.

Saroja Pharma IPO Expected Returns?

The Saroja Pharma expected return is 0%.

How much will be the listing gain in Saroja Pharma IPO?

Saroja Pharma IPO will get listing gain of 0%. (Approx.)

Leave a Reply

Your email address will not be published. Required fields are marked *